- cross-posted to:
- health
- cross-posted to:
- health
I missed this before, but apparently we’re now nearly a year into Merck and Moderna’s Phase-3 trials of a novel mRNA vaccine (mRNA-4157) in combination with Keytruda to slow or halt aggressive melanoma growth. (press release), and about 4 months into a similar Phase 3 trial of the same drug combo for small cell lung cancer (press release). Here’s hoping that 2025 is the year we cure (some kinds of) cancer!
the original article (linked in this article; from The Guardian) is over 8 months old.
Yup. I linked both the original press release about melanoma as well as the one from October about the similar trial for lung cancer.